Jubilant Pharmova rose 1.70% to Rs 849.70 after the company said its subsidiary, Jubilant Pharma, received a favorable and unanimous judgment from the US Court of Appeals.Jubilant Pharma, a subsidiary of Jubilant Pharmova, announced that it has received a favorable and unanimous judgment from the United States Court of Appeals summarily affirming Jubilant s earlier favorable rulings from the US Patent Office ( PTAB ) and the US International Trade Commission ( ITC ). These two rulings by the Appellate Court deny the appeals filed by Bracco Diagnostics, Inc.
Jubilant successfully challenged Bracco s patent infringement claims in an Inter Parties Review (IPR) proceeding before the U.S. Patent Office as well as in a separate proceeding in the ITC. In both instances, Jubilant was successful.